<VariationArchive RecordType="classified" VariationID="156615" VariationName="NM_001110792.2(MECP2):c.1165_1234del (p.Lys389fs)" VariationType="Deletion" Accession="VCV000156615" Version="4" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2023-08-06" DateCreated="2014-11-02" MostRecentSubmission="2023-02-18">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="166469" VariationID="156615">
      <GeneList>
        <Gene Symbol="MECP2" FullName="methyl-CpG binding protein 2" GeneID="4204" HGNC_ID="HGNC:6990" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154021573" stop="154097717" display_start="154021573" display_stop="154097717" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153287263" stop="153363187" display_start="153287263" display_stop="153363187" Strand="-" />
          </Location>
          <OMIM>300005</OMIM>
          <Haploinsufficiency last_evaluated="2021-02-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MECP2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-02-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MECP2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001110792.2(MECP2):c.1165_1234del (p.Lys389fs)</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154030630" stop="154030699" display_start="154030630" display_stop="154030699" variantLength="70" positionVCF="154030629" referenceAlleleVCF="GTGGGGTCCTCGGAGCTCTCGGGCTCAGGTGGAGGTGGGGGCAGGGGTGGGAGCAGTGGCACGGGGGCCTT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153296081" stop="153296150" display_start="153296081" display_stop="153296150" variantLength="70" positionVCF="153296080" referenceAlleleVCF="GTGGGGTCCTCGGAGCTCTCGGGCTCAGGTGGAGGTGGGGGCAGGGGTGGGAGCAGTGGCACGGGGGCCTT" alternateAlleleVCF="G" />
      </Location>
      <OtherNameList>
        <Name>NM_001110792.2(MECP2):c.1165_1234del</Name>
        <Name>p.Lys389fs</Name>
      </OtherNameList>
      <ProteinChange>K389fs</ProteinChange>
      <ProteinChange>K284fs</ProteinChange>
      <ProteinChange>K377fs</ProteinChange>
      <ProteinChange>K154fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_764" sequenceAccession="LRG_764">
            <Expression>LRG_764:g.111405_111474del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_764t1" sequenceAccession="LRG_764t1">
            <Expression>LRG_764t1:c.1165_1234del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_764p1" sequenceAccession="LRG_764p1" change="p.Lys389fs">
            <Expression>LRG_764p1:p.Lys389fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_764t2" sequenceAccession="LRG_764t2">
            <Expression>LRG_764t2:c.1129_1198del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_764p2" sequenceAccession="LRG_764p2" change="p.Lys377fs">
            <Expression>LRG_764p2:p.Lys377fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004992.3" sequenceAccession="NM_004992" sequenceVersion="3" change="c.1129_1198del70">
            <Expression>NM_004992.3:c.1129_1198del70</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.153296086_153296155del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.153296086_153296155del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.154030635_154030704del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.154030635_154030704del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007107.3" sequenceAccession="NG_007107" sequenceVersion="3" change="g.111405_111474del">
            <Expression>NG_007107.3:g.111405_111474del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001110792.2" sequenceAccession="NM_001110792" sequenceVersion="2" change="c.1165_1234del" MANESelect="true">
            <Expression>NM_001110792.2:c.1165_1234del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001104262.1" sequenceAccession="NP_001104262" sequenceVersion="1" change="p.Lys389fs">
            <Expression>NP_001104262.1:p.Lys389fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001316337.2" sequenceAccession="NM_001316337" sequenceVersion="2" change="c.850_919del">
            <Expression>NM_001316337.2:c.850_919del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001303266.1" sequenceAccession="NP_001303266" sequenceVersion="1" change="p.Lys284fs">
            <Expression>NP_001303266.1:p.Lys284fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369391.2" sequenceAccession="NM_001369391" sequenceVersion="2" change="c.850_919del">
            <Expression>NM_001369391.2:c.850_919del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356320.1" sequenceAccession="NP_001356320" sequenceVersion="1" change="p.Lys284fs">
            <Expression>NP_001356320.1:p.Lys284fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369392.2" sequenceAccession="NM_001369392" sequenceVersion="2" change="c.850_919del">
            <Expression>NM_001369392.2:c.850_919del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356321.1" sequenceAccession="NP_001356321" sequenceVersion="1" change="p.Lys284fs">
            <Expression>NP_001356321.1:p.Lys284fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369393.2" sequenceAccession="NM_001369393" sequenceVersion="2" change="c.850_919del">
            <Expression>NM_001369393.2:c.850_919del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356322.1" sequenceAccession="NP_001356322" sequenceVersion="1" change="p.Lys284fs">
            <Expression>NP_001356322.1:p.Lys284fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369394.2" sequenceAccession="NM_001369394" sequenceVersion="2" change="c.850_919del">
            <Expression>NM_001369394.2:c.850_919del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356323.1" sequenceAccession="NP_001356323" sequenceVersion="1" change="p.Lys284fs">
            <Expression>NP_001356323.1:p.Lys284fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001386137.1" sequenceAccession="NM_001386137" sequenceVersion="1" change="c.460_529del">
            <Expression>NM_001386137.1:c.460_529del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001373066.1" sequenceAccession="NP_001373066" sequenceVersion="1" change="p.Lys154fs">
            <Expression>NP_001373066.1:p.Lys154fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001386138.1" sequenceAccession="NM_001386138" sequenceVersion="1" change="c.460_529del">
            <Expression>NM_001386138.1:c.460_529del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001373067.1" sequenceAccession="NP_001373067" sequenceVersion="1" change="p.Lys154fs">
            <Expression>NP_001373067.1:p.Lys154fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001386139.1" sequenceAccession="NM_001386139" sequenceVersion="1" change="c.460_529del">
            <Expression>NM_001386139.1:c.460_529del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001373068.1" sequenceAccession="NP_001373068" sequenceVersion="1" change="p.Lys154fs">
            <Expression>NP_001373068.1:p.Lys154fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004992.4" sequenceAccession="NM_004992" sequenceVersion="4" change="c.1129_1198del" MANEPlusClinical="true">
            <Expression>NM_004992.4:c.1129_1198del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004983.1" sequenceAccession="NP_004983" sequenceVersion="1" change="p.Lys377fs">
            <Expression>NP_004983.1:p.Lys377fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004992.3" sequenceAccession="NM_004992" sequenceVersion="3" change="c.1129_1198del">
            <Expression>NM_004992.3:c.1129_1198del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA294622" DB="ClinGen" />
        <XRef Type="rs" ID="1557135353" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">70-nt deletion in exon 4 of gene MECP2.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001110792.2(MECP2):c.1165_1234del (p.Lys389fs) AND not provided" Accession="RCV000144758" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2013-12-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001110792.2(MECP2):c.1165_1234del (p.Lys389fs) AND Rett syndrome" Accession="RCV000590874" Version="2">
        <ClassifiedConditionList TraitSetID="3215">
          <ClassifiedCondition DB="MedGen" ID="C0035372">Rett syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2022-07-21" SubmissionCount="2">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001110792.2(MECP2):c.1165_1234del (p.Lys389fs) AND X-linked intellectual disability-psychosis-macroorchidism syndrome" Accession="RCV003126509" Version="1">
        <ClassifiedConditionList TraitSetID="3217">
          <ClassifiedCondition DB="MedGen" ID="C0796222">X-linked intellectual disability-psychosis-macroorchidism syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-06-29" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-07-21" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2014-11-02" MostRecentSubmission="2023-02-18">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Uncertain significance</Description>
        <Citation Type="general">
          <ID Source="PubMed">29961512</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/b50a48a5-25e8-47e2-a079-2c0c7b3b7de9</URL>
        </Citation>
        <DescriptionHistory Dated="2022-09-08">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2019-07-02">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-05-29">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-03-23">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3217" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="2902" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PPM-X syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">X-linked intellectual disability-psychosis-macroorchidism syndrome</ElementValue>
                <XRef ID="MONDO:0010235" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 13</ElementValue>
                <XRef Type="MIM" ID="300055" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300005.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300005.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300005.0022" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300005.0033" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300005.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300005.0035" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MRXS13</ElementValue>
                <XRef Type="MIM" ID="300055" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3506" />
                <XRef ID="3506" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of MECP2-related phenotypes in females ranges from classic Rett syndrome to variant Rett syndrome with a broader clinical phenotype (either milder or more severe than classic Rett syndrome) to mild learning disabilities; the spectrum in males ranges from severe neonatal encephalopathy to pyramidal signs, parkinsonism, and macroorchidism (PPM-X) syndrome to severe syndromic/nonsyndromic intellectual disability. Females: Classic Rett syndrome, a progressive neurodevelopmental disorder primarily affecting girls, is characterized by apparently normal psychomotor development during the first six to 18 months of life, followed by a short period of developmental stagnation, then rapid regression in language and motor skills, followed by long-term stability. During the phase of rapid regression, repetitive, stereotypic hand movements replace purposeful hand use. Additional findings include fits of screaming and inconsolable crying, autistic features, panic-like attacks, bruxism, episodic apnea and/or hyperpnea, gait ataxia and apraxia, tremors, seizures, and acquired microcephaly. Males: Severe neonatal-onset encephalopathy, the most common phenotype in affected males, is characterized by a relentless clinical course that follows a metabolic-degenerative type of pattern, abnormal tone, involuntary movements, severe seizures, and breathing abnormalities. Death often occurs before age two years.</Attribute>
                <XRef ID="NBK1497" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301670</ID>
                <ID Source="BookShelf">NBK1497</ID>
              </Citation>
              <XRef ID="3077" DB="Orphanet" />
              <XRef ID="C0796222" DB="MedGen" />
              <XRef ID="MONDO:0010235" DB="MONDO" />
              <XRef Type="MIM" ID="300055" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3215" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3622" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Rett's disorder</ElementValue>
                <XRef ID="Rett+syndrome/6294" DB="Genetic Alliance" />
                <XRef ID="68618008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Autism, dementia, ataxia, and loss of purposeful hand use</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Rett syndrome</ElementValue>
                <XRef ID="MONDO:0010726" DB="MONDO" />
                <XRef ID="778" DB="Orphanet" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">RTS</ElementValue>
                <XRef Type="MIM" ID="312750" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">RTT</ElementValue>
                <XRef Type="MIM" ID="312750" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">MECP2-Related Disorders</Attribute>
                <XRef ID="NBK1497" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of MECP2-related phenotypes in females ranges from classic Rett syndrome to variant Rett syndrome with a broader clinical phenotype (either milder or more severe than classic Rett syndrome) to mild learning disabilities; the spectrum in males ranges from severe neonatal encephalopathy to pyramidal signs, parkinsonism, and macroorchidism (PPM-X) syndrome to severe syndromic/nonsyndromic intellectual disability. Females: Classic Rett syndrome, a progressive neurodevelopmental disorder primarily affecting girls, is characterized by apparently normal psychomotor development during the first six to 18 months of life, followed by a short period of developmental stagnation, then rapid regression in language and motor skills, followed by long-term stability. During the phase of rapid regression, repetitive, stereotypic hand movements replace purposeful hand use. Additional findings include fits of screaming and inconsolable crying, autistic features, panic-like attacks, bruxism, episodic apnea and/or hyperpnea, gait ataxia and apraxia, tremors, seizures, and acquired microcephaly. Males: Severe neonatal-onset encephalopathy, the most common phenotype in affected males, is characterized by a relentless clinical course that follows a metabolic-degenerative type of pattern, abnormal tone, involuntary movements, severe seizures, and breathing abnormalities. Death often occurs before age two years.</Attribute>
                <XRef ID="NBK1497" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5696" />
                <XRef ID="5696" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301670</ID>
                <ID Source="BookShelf">NBK1497</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="pmc">3111012</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23519317</ID>
              </Citation>
              <XRef ID="3095" DB="Orphanet" />
              <XRef ID="778" DB="Orphanet" />
              <XRef ID="C0035372" DB="MedGen" />
              <XRef ID="MONDO:0010726" DB="MONDO" />
              <XRef Type="MIM" ID="312750" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="5025010" SubmissionDate="2022-09-06" DateLastUpdated="2022-09-10" DateCreated="2022-09-10">
        <ClinVarSubmissionID localKey="b50a48a5-25e8-47e2-a079-2c0c7b3b7de9" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002569942" DateUpdated="2022-09-10" DateCreated="2022-09-10" Type="SCV" Version="1" SubmitterName="ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel" OrgID="508065" OrganizationCategory="consortium" OrgAbbreviation="Rett/AS VCEP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-21">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/b50a48a5-25e8-47e2-a079-2c0c7b3b7de9</URL>
          </Citation>
          <Comment>The c.1129_1198del p.(Lys377ProfsTer9) variant in MECP2 (NM_004992.3) is absent from gnomAD (PM2_supporting). The p.(Lys377ProfsTer9) variant in MECP2 is predicted to cause a premature stop codon that leads to a truncated or absent protein in a gene where loss-of-function is an established mechanism. There is significant evidence that loss of this region of the gene is pathogenic (PVS1). The p.(Lys377ProfsTer9) variant has been reported in 1 individual with an epilepsy and neurodevelopmental disorder (PMID 29655203), and 1 individual with developmental delay and autism where it was inherited from a mother with a history of learning difficulties (ClinVar SCV000190972.2) (PS4_Supporting has not been applied as it is unclear whether these citations reflect two independent occurrences). The p.(Lys377ProfsTer9) variant has also been found in a patient with an alternate molecular basis of disease (PMID 29961512). This patient had early infantile epileptic encephalopathy, however did not meet the diagnostic criteria for either typical or atypical Rett. The p.(Lys377ProfsTer9) variant was found to be inherited from this patient's father, who was reported as having a history of seizures as a child and learning disability but was otherwise described as unaffected (BS2_Supporting). Furthermore, this patient was also found to be heterozygous for a de novo (biological parentage confirmed) GNAO1 missense variant that was deemed to be causative of this patient's clinical presentation (BP5). In summary, the c.1129_1198del p.(Lys377ProfsTer9) variant in MECP2 is classified as a Variant of Uncertain Significance based on the ACMG/AMP criteria (PVS1, PM2_supporting, BP5, BS2_Supporting).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen RettAS ACMG Specifications V2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/bjzrjqbb/clingen_rettas_acmg_specifications_v2.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MECP2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_001110792.2(MECP2):c.1165_1234del</Name>
            <Name>p.Lys389fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.11:g.154030635_154030704del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0010726" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12018787</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7104401" SubmissionDate="2023-02-15" DateLastUpdated="2023-02-18" DateCreated="2023-02-18">
        <ClinVarSubmissionID localKey="NM_004992.3:c.1129_1198del|OMIM:300055" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003803868" DateUpdated="2023-02-18" DateCreated="2023-02-18" Type="SCV" Version="1" SubmitterName="Department of Genetics, Rouen University Hospital, Normandy Center for Genomic and Personalized Medicine" OrgID="506968" OrganizationCategory="laboratory" OrgAbbreviation="LABOGENMOL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004992.3:c.1129_1198del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="300055" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12506292</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="338121" SubmissionDate="2014-10-29" DateLastUpdated="2014-11-02" DateCreated="2014-11-02">
        <ClinVarSubmissionID localKey="32637" />
        <ClinVarAccession Accession="SCV000190972" DateUpdated="2014-11-02" DateCreated="2014-11-02" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-12-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.1129_1198del70 mutation results in a deletion of 70 base pairs located in the deletion-prone region at the 3' end of the MECP2 gene. This deletion causes a frameshift starting with codon Lysine 377, changes this amino acid to a Proline residue, and creates a premature Stop codon at position 9 of the new reading frame, denoted p.Lys377ProfsX9. This deletion results in the replacement of the last 110 amino acids of the protein with 8 aberrant amino acids and is predicted to cause loss of normal protein function through protein truncation. This mutation has not been reported previously to our knowledge, although large deletions in this region of the gene have been identified in patients with classic and atypical Rett syndrome. The variant is found in INFANT-EPI panel(s).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MECP2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.K377Pfsx9</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004992.3:c.1129_1198del70</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GDX_AllTest_AllPolys_06102014</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1372234" SubmissionDate="2017-09-11" DateLastUpdated="2018-03-23" DateCreated="2018-03-23">
        <ClinVarSubmissionID localKey="p.Lys377ProfsX9" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000700176" DateUpdated="2018-03-23" DateCreated="2018-03-23" Type="SCV" Version="2" SubmitterName="Tgen's Center For Rare Childhood Disorders, Translational Genomics Research Institute (TGEN)" OrgID="505520" OrganizationCategory="laboratory" OrgAbbreviation="TGEN-C4RCD" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Benign</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">29961512</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">29961512</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Gerald et al. (Semin Pediatr Neurol. 2018)</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">29961512</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <NamePlatform>HiSeq</NamePlatform>
              <TypePlatform>Next-gen sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Epilepsy Panel</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Proband>no</Proband>
            </Sample>
            <Method>
              <NamePlatform>HiSeq</NamePlatform>
              <TypePlatform>Next-gen sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Epilepsy Panel</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MECP2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004992.3:c.1129_1198del70</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Rett Syndrome</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">29961512</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29961512</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29961512</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB3034958</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7104401" TraitType="Disease" MappingType="XRef" MappingValue="300055" MappingRef="OMIM">
        <MedGen CUI="C0796222" Name="X-linked intellectual disability-psychosis-macroorchidism syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5025010" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0010726" MappingRef="MONDO">
        <MedGen CUI="C0035372" Name="Rett syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="338121" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1372234" TraitType="Disease" MappingType="Name" MappingValue="Rett Syndrome" MappingRef="Preferred">
        <MedGen CUI="C0035372" Name="Rett syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

